BRCA2

You have access
Comparison of BRCA2 Single Nucleotide Variants Between Japanese Patients With Familial Prostate Cancer, Sporadic Prostate Cancer, and Benign Prostatic Hyperplasia
MASANORI AOKI, HIROSHI MATSUI, SOTA KURIHARA, NOBUAKI OHTAKE, SHUN NAKAZAWA, YUSUKE TSUJI, YUJI FUJIZUKA, SEIJI ARAI, MASASHI NOMURA, YOSHITAKA SEKINE, HIDEKAZU KOIKE, KAZUHIRO SUZUKI and YOSHIYUKI MIYAZAWA

Anticancer Research May 2025, 45 (5) 2195-2204; DOI: https://doi.org/10.21873/anticanres.17593
You have access
PARP Inhibitor Sensitizes BRCA-mutant Pancreatic Cancer to Oxaliplatin by Suppressing the CDK1/BRCA1 Axis
CHORONG KIM, DANBEE KIM, DA SOL LEE, SEONMIN LEE, CHANGHOON YOO and KYU-PYO KIM

Anticancer Research December 2023, 43 (12) 5523-5534; DOI: https://doi.org/10.21873/anticanres.16754
You have access
Synergistic Effects of Arsenite on Radiosensitization of Glioblastoma Cells
YASUHARU NINOMIYA, DONG YU, EMIKO SEKINE-SUZUKI and TETSUO NAKAJIMA

Anticancer Research August 2017, 37 (8) 4111-4117;
You have access
Thyroid Hormones and Vitamin D in Patients with Breast Cancer with Mutations in BRCA1 or BRCA2 Genes
THOMAS KOLBEN, THOMAS HARY, LESCA M. HOLDT, THERESA M. SCHWARZ, CHRISTINE GOESS, RACHEL WUERSTLEIN, JULIA GALLWAS, BETTINA TOTH, TOBIAS WEISSENBACHER, UDO JESCHKE, NADIA HARBECK and NINA DITSCH

Anticancer Research June 2016, 36 (6) 3185-3190;

Main menu